KR20040015368A - 항암제 및 항증식제로 유용한 사이클린 의존성 키나제억제제인 아실세미카르바지드 - Google Patents

항암제 및 항증식제로 유용한 사이클린 의존성 키나제억제제인 아실세미카르바지드 Download PDF

Info

Publication number
KR20040015368A
KR20040015368A KR10-2004-7000762A KR20047000762A KR20040015368A KR 20040015368 A KR20040015368 A KR 20040015368A KR 20047000762 A KR20047000762 A KR 20047000762A KR 20040015368 A KR20040015368 A KR 20040015368A
Authority
KR
South Korea
Prior art keywords
substituted
alkyl
group
nhc
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR10-2004-7000762A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 누기엘
데이비드 카리니
수잔 디메오
아눕 비드완스
에디 유에
Original Assignee
브리스톨-마이어스 스퀴브 파마 컴파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브리스톨-마이어스 스퀴브 파마 컴파니 filed Critical 브리스톨-마이어스 스퀴브 파마 컴파니
Publication of KR20040015368A publication Critical patent/KR20040015368A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR10-2004-7000762A 2001-07-16 2002-07-16 항암제 및 항증식제로 유용한 사이클린 의존성 키나제억제제인 아실세미카르바지드 Withdrawn KR20040015368A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/906,963 2001-07-16
US09/906,963 US6593356B2 (en) 1999-10-20 2001-07-16 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
PCT/US2002/022663 WO2003007883A2 (en) 2001-07-16 2002-07-16 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents

Publications (1)

Publication Number Publication Date
KR20040015368A true KR20040015368A (ko) 2004-02-18

Family

ID=25423309

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7000762A Withdrawn KR20040015368A (ko) 2001-07-16 2002-07-16 항암제 및 항증식제로 유용한 사이클린 의존성 키나제억제제인 아실세미카르바지드

Country Status (15)

Country Link
US (1) US6593356B2 (enExample)
EP (1) EP1417177A4 (enExample)
JP (1) JP2004536853A (enExample)
KR (1) KR20040015368A (enExample)
CN (1) CN1553900A (enExample)
BR (1) BR0211203A (enExample)
CA (1) CA2453594A1 (enExample)
HU (1) HUP0401588A3 (enExample)
IL (1) IL159863A0 (enExample)
MX (1) MXPA04000531A (enExample)
NO (1) NO20040175L (enExample)
PL (1) PL366912A1 (enExample)
RU (1) RU2004104329A (enExample)
WO (1) WO2003007883A2 (enExample)
ZA (1) ZA200400332B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048844A1 (en) * 1999-10-20 2004-03-11 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
JP3821090B2 (ja) * 2002-10-22 2006-09-13 トヨタ自動車株式会社 内燃機関の始動制御装置
US7456169B2 (en) 2003-02-27 2008-11-25 Abbott Laboratories Inc. Heterocyclic kinase inhibitors
US7320986B2 (en) 2003-03-07 2008-01-22 Abbott Labortories Fused tri and tetra-cyclic pyrazole kinase inhibitors
ES2551293T3 (es) 2004-03-24 2015-11-17 Abbvie Inc. Inhibidores de quinasas de pirazol tricíclicos
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
EP3001194B1 (en) 2009-08-31 2019-04-17 Abbott Diabetes Care, Inc. Medical devices and methods
WO2011162843A1 (en) 2010-03-24 2011-12-29 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
LT4056105T (lt) 2011-12-11 2024-01-10 Abbott Diabetes Care, Inc. Analitės jutiklių įrenginiai
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
EP3377908B1 (en) 2015-11-18 2020-08-05 Genzyme Corporation Biomarker of polycystic kidney disease and uses thereof
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
CN114641466B (zh) 2019-06-12 2025-09-30 诺瑟拉有限公司 磺酰脲衍生物及其用途
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407103B2 (en) * 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
DE69940951D1 (de) * 1998-04-21 2009-07-16 Bristol Myers Squibb Pharma Co Nd wachstumshemmende mittel
US6291504B1 (en) * 1999-10-20 2001-09-18 Dupont Pharmaceuticals Company Acylsemicarbazides and their uses
JP2004524277A (ja) * 2000-10-20 2004-08-12 ブリストル−マイヤーズ スクイブ ファーマ カンパニー アシルセミカルバジド及びサイクリン依存性キナーゼ（ｃｄｋ）阻害剤としてのその使用
US6706718B2 (en) * 2000-12-01 2004-03-16 Bristol-Myers Squibb Company 3-(2,4-dimethylthiazol-5-yl)indeno[1,2-c]pyrazol-4-one derivatives and their uses

Also Published As

Publication number Publication date
EP1417177A4 (en) 2005-10-19
US20030073686A1 (en) 2003-04-17
WO2003007883A3 (en) 2003-05-22
US6593356B2 (en) 2003-07-15
HUP0401588A3 (en) 2005-06-28
JP2004536853A (ja) 2004-12-09
PL366912A1 (en) 2005-02-07
NO20040175L (no) 2004-03-12
CN1553900A (zh) 2004-12-08
WO2003007883A2 (en) 2003-01-30
ZA200400332B (en) 2005-06-29
CA2453594A1 (en) 2003-01-30
RU2004104329A (ru) 2005-07-10
IL159863A0 (en) 2004-06-20
HUP0401588A2 (hu) 2005-01-28
MXPA04000531A (es) 2004-05-04
BR0211203A (pt) 2004-09-28
EP1417177A2 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
JP4665239B2 (ja) 抗癌剤および抗増殖性薬剤としての５−アミノインデノ［１，２−ｃ］ピラゾール−４−オン
US6407103B2 (en) Indeno [1,2-c] pyrazol-4-ones and their uses
US6593356B2 (en) Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
CA2349330C (en) Nitrogen containing heterobicycles as factor xa inhibitors
US6291504B1 (en) Acylsemicarbazides and their uses
DE69922823T2 (de) 6-SUBSTITUIERTE PYRAZOLO(3,4-d)PYRIMIDIN-4-ONE VERWENDBAR ALS CYCLIN-ABHÄNGIGE KINASEHEMMER
US5605896A (en) Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
KR19990087504A (ko) 피리미도[5,4-d]피리미딘, 이를 함유하는 약제, 이의 용도 및이의 제조방법
NL8903143A (nl) Verbinding met een relaxatie-activiteit voor de gladde spier van bloedvaten, werkwijze voor de bereiding hiervan en farmaceutische samenstelling die deze verbinding bevat.
US7250435B2 (en) Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
US6706718B2 (en) 3-(2,4-dimethylthiazol-5-yl)indeno[1,2-c]pyrazol-4-one derivatives and their uses
DE69715870T2 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
JP2009541472A (ja) ピラゾリルベンゾイミダゾール誘導体、これらを含有する組成物及びこれらの使用
JP2004524277A (ja) アシルセミカルバジド及びサイクリン依存性キナーゼ（ｃｄｋ）阻害剤としてのその使用
AU639581B2 (en) 1-(substituted pyridinylamino)-1h-indole-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments
WO2006054912A1 (fr) Derives d'aryl(hetaryl)-3-aminomethylchinolone-2 utilises en tant qu'inhibiteurs de no-synthetase et de cyclo-oxygenase-2, procedes de leur fabrication et compositions pharmaceutiques sur leur base
US8114899B2 (en) 2H- or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
AU2002318254A1 (en) Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
MXPA00010299A (en) 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents
CN114573604B (zh) 一类基于喹诺酮的化合物、其制备方法、包含其的药物组合物及其用途
MXPA00010551A (en) Quinolones used as mrs inhibitors and bactericides
PL65976B1 (enExample)

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040116

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid